IPO registrations (S-1, F-1) · Registrants
APP Pharmaceuticals, Inc.
- SEC CIK
- 1141399 · filings on EDGAR ↗
- Name on the registration
- AMERICAN PHARMACEUTICAL PARTNERS INC /CA/
- Former names
- Abraxis BioScience, Inc. (2006–2007); Abraxis BioScience, Inc. (ABBI) (2006–2006); AMERICAN PHARMACEUTICAL PARTNERS INC /DE/ (2002–2006); AMERICAN PHARMACEUTICAL PARTNERS INC /CA/ (2001–2002)
- Registration
- Form S-1, first filed 2001-10-03, last 2001-12-13; 1 initial registration, 3 amendments
- Outcome
- Final prospectus filed 2001-12-14
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 1501 EAST WOODFIELD ROAD, SUITE 300 EAST, Schaumburg, IL 60173-5837
- EIN
- 68-0389419
- EDGAR entity type
- operating
- Insiders and CEO pay
- APP Pharmaceuticals, Inc. on the corporate pages
Offering terms
- Proposed price range
- $13.00–$16.00 per share (S-1/A filed 2001-12-13)
- Final price
- $16.00 per share, within the range (424B4 filed 2001-12-14, an initial public offering)
- Shares sold
- 9,000,000
- Gross proceeds
- $144,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol APPX
- Lead underwriters
- CIBC World Markets (3,675,000 shares); BofA Securities (1,837,500 shares); UBS (1,837,500 shares)
- Syndicate
- ABN AMRO (150,000); Bear Stearns (150,000); Cowen (150,000); Merrill Lynch (150,000); RBC Capital Markets (150,000); Thomas Weisel Partners (150,000); Piper Sandler (150,000); Wachovia (150,000); Emerging Growth Equities, Ltd (75,000); FBR (75,000); KBW (75,000); Leerink Partners (75,000); Legg Mason (75,000); Sandler O'Neill & Partners, L.P (75,000)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Federal award recipient: APP PHARMACEUTICALS, INC. Fuzzy (name and state)
- Lobbying client: APP PHARMACEUTICALS Fuzzy (name and state)
- SEC filer: Abraxis BioScience, Inc. EXACT (CIK (EXACT))
- Person page: Michael D Blaszyk Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 5
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2001-10-03 | S-1 | S-1 (registration) | AMERICAN PHARMACEUTICAL PARTNERS INC /CA/ | 0000898430-01-502716 ↗ |
| 2001-11-20 | S-1/A | S-1/A (amendment) | AMERICAN PHARMACEUTICAL PARTNERS INC /CA/ | 0000898430-01-503649 ↗ |
| 2001-12-11 | S-1/A | S-1/A (amendment) | AMERICAN PHARMACEUTICAL PARTNERS INC /CA/ | 0000898430-01-503826 ↗ |
| 2001-12-13 | S-1/A | S-1/A (amendment) | AMERICAN PHARMACEUTICAL PARTNERS INC /CA/ | 0000898430-01-503863 ↗ |
| 2001-12-14 | 424B4 | 424B4 (final prospectus) | AMERICAN PHARMACEUTICAL PARTNERS INC /CA/ | 0000898430-01-503883 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2001-12-13 | S-1/A | registration statement | $13.00–$16.00 | 9,000,000 | - | Nasdaq APPX | 3 | primary document; range, price line, shares headline, proceeds computed, price outside the range dropped, cover names 3 | document ↗ | |
| 2001-12-14 | 424B4 | final prospectus | $16.00 | 9,000,000 | $144,000,000 | Nasdaq APPX | 17 | primary document; price sentence, shares headline, proceeds table, underwriting table 17, cover names 3 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Weidenbruch John | Officer | Acting General Counsel | 1 | 2006 | |
| SOON SHIONG PATRICK | Director,Officer; Director,Officer,TenPercentOwner; Director,TenPercentOwner | Chairman and CEO; Executive Chairman | 5 | 2006–2008 | |
| WILLIAMS NICOLE | Officer | Chief Financial Officer | 2 | 2006 | |
| California Capital Limited Partnership | TenPercentOwner | 3 | 2006–2008 | ||
| Montagner Carlo | Officer | President, Abraxis Oncology | 2 | 2006 | |
| Themba 2005 Trust I | TenPercentOwner | 2 | 2006–2008 | ||
| Themba 2005 Trust II | TenPercentOwner | 2 | 2006–2008 | ||
| NIMER STEPHEN | Director | 2 | 2006 | ||
| Maroun Richard E | Officer | CAO and General Counsel; Chief Administrative Officer | 3 | 2006–2008 | |
| Pauli Ronald | Officer | Chief Financial Officer | 2 | 2006 | |
| Harmon J Frank | Officer | COO of Abraxis Phar. Prod Div.; Exec. VP and COO; Exec. VP, Global Operations | 4 | 2006–2008 | |
| Silberg Thomas | Officer | Chief Executive Officer & Pres; Executive Vice President; President of Pharm. prds. Div | 3 | 2006–2008 | |
| Wendel Bruce | Officer | Exec. VP Corporate Development | 1 | 2006 | |
| BLASZYK MICHAEL D | Director | 4 | 2006–2008 | person page Fuzzy | |
| CALHOUN KIRK K | Director | 1 | 2006 | ||
| CHEN DAVID | Director | 1 | 2006 | ||
| SHAPIRO LEONARD | Director | 1 | 2006 | ||
| SITRICK MICHAEL S | Director | 4 | 2006–2008 | ||
| Gopalakrishnan Lisa | Officer | Executive VP | 2 | 2006 | |
| SYKES RICHARD | Director | 2 | 2006 | ||
| DePina Stuart | Director | 3 | 2007–2008 | ||
| Gopala Krishna | Director | 2 | 2007 | ||
| Pizza Joseph M | Director | 3 | 2007–2008 | ||
| Tajak Richard J. | Officer | Exec. VP & CFO | 2 | 2008 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Federal award recipient | APP PHARMACEUTICALS, INC. | IL | Federal spending (USAspending) | name and state |
| Lobbying client | APP PHARMACEUTICALS | IL | Federal lobbying (LDA) | name and state |
| SEC filer | APP Pharmaceuticals, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | APP Pharmaceuticals, LLC | IL | Trademarks (USPTO) | name and state |
| Person page | Michael D Blaszyk | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, IL first:
- XERIS PHARMACEUTICALS INC IL
- Sagent Pharmaceuticals, Inc. IL
- Wellness Center USA, Inc. IL
- Durata Therapeutics, Inc. IL
- AbbVie Inc. IL
- PharMEDium Healthcare Holdings, Inc. IL
- Baxalta Inc IL
- Accelerated Pharma, Inc. IL
- Monopar Therapeutics IL
- Aptinyx Inc. IL
In other datasets, the same topic (Health) in IL:
- Nonprofit: 5 LOAVES 2 FISHES FOUNDATION INC (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health